Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion type Assertion NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_head.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion description "[Loss of GPX1 expression was significantly associated with advanced gastric cancer (p=0.039) and lymphatic invasion (p=0.010); loss of GPX3 expression was associated with advanced gastric cancer (p<0.001) and lymph node metastasis (p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_provenance.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion evidence source_evidence_literature NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_provenance.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion SIO_000772 22843889 NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_provenance.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion wasDerivedFrom befree-20140225 NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_provenance.
- NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_assertion wasGeneratedBy ECO_0000203 NP489219.RAfA2uRcpdNQwq0D5XCdym6kopW6_NlQSzxSs9UEasStY130_provenance.